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Beyond the rhetoric: Towards a more effective and humane drug 
policy framework in South Africa
Charles Parry, Bronwyn Myers
The March 2011 Anti-Substance Abuse Summit in Durban 
continued the outdated approach to policy around illicit drugs 
in South Africa.  It missed opportunities for discussing how to 
impact significantly on the health and social harms associated with 
problematic drug use and reduce the burden of drug-related cases 
in the criminal justice system. The government needs to move 
away from the political rhetoric of a ‘drug-free society’ and start 
the real work of formulating and implementing an evidence-based 
drug policy that learns from the experiences of other countries 
around decriminalising drug use; takes into account differences 
in the harms resulting from different classes of drugs; adopts a 
rights-based, public health approach to policy; and identifies a 
single (accountable) agency that has the authority to oversee policy 
implementation. In addition, consensus is needed on the short-, 
medium- and long-term priorities for drug policy implementation. 
The 17 evidence-based drug policy strategies identified by Babor 
et al. may serve as a useful starting point for policy development.
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In March 2011 the Department of Social Development and the 
Central Drug Authority (CDA) hosted the 2nd Biennial Anti-
Substance Abuse Summit in Durban with the theme ‘An Integrated 
Approach: Towards a Drug-free Society’. Some of the country’s top 
politicians, including the President and eight cabinet members, were 
participants. The main emphasis was on alcohol, and where illicit 
drugs were referred to the emphasis was on the link between drugs 
and crime, drug supply, and the need for treating people with alcohol 
or drug dependence. Little distinction was made between the harm 
caused by different types of drugs, and no distinction was made 
between persons who use and persons who are dependent on drugs.1 
This continued focus on the drugs-crime nexus, and the emphasis 
on controlling and containing people with drug-related problems, is 
a concern as it reflects an outdated approach to drug policy that has 
been shown to be ineffective and inhumane internationally.2,3 Supply-
orientated policies have had adverse consequences for people who 
use drugs, including missed opportunities to reduce the personal and 
social harms associated with problematic drug use.3 We contend that 
to be effective, South African drug policy needs urgent reworking. 
While there are common issues relating to policy around alcohol and 
illicit drugs, the country would be served best by separating policy 
development in these two areas and then investigating whether there 
can be synergies between the two during implementation. This paper 
focuses on policy around illicit drug use.
What is the status of drug policy 
development and implementation in 
South Africa?
Policy development around illicit drug use is being driven by various 
government departments and ministries, the CDA, and since late 
2010 the Inter-ministerial Committee on Substance Abuse (IMC). 
The second National Drug Master Plan (NDMP; 2006 - 2011)4 
provides the policy framework for addressing drug use in the country 
and the legislative framework is provided by the Prevention and 
Treatment of Substance Abuse Act 70 of 2008.5 The NDMP’s major 
limitation is that it does not translate generic policy statements 
into clear recommendations for action. This is left in the hands 
of various national departments and is mostly devolved to the 
provinces. Devolving this function to the level of the province has 
resulted in major differences in drug policy between the provinces, 
both in terms of the stage of policy development and position on 
various issues. Some provinces, such as the Western Cape, have a 
coherent and relatively forward-thinking policy framework that 
drives resource allocation; others either lack a framework or still 
focus predominantly on law enforcement. This fragmentation makes 
it difficult to develop and implement an evidence-based national 
drug policy framework. Another challenge is the lack of leadership 
on drug-related issues, both at national and provincial levels.6 This 
has hampered progress as no single person (or authority) has been 
responsible for driving the implementation of policies or accountable 
for the successes and failures of policies. In theory this was the CDA 
and provincial substance abuse forums, but in practice they have 
lacked the authority and resources to take this on.6
Although the NDMP is being revised, there is no reason to believe 
that there will be any major shifts from the current conservative 
focus which still calls for a ‘drug-free’ society. Among the various 
international policy options, South Africa’s policies have a strong 
focus on supply reduction through law enforcement and policing, 
despite rhetoric about having a developmental approach to drug use.4 
These policies are not particularly humane, as people who use drugs 
are still imprisoned for drug possession and have limited access to 
evidence-based interventions. They also have had unintended adverse 
consequences for individuals and society, including overburdening 
the criminal justice system with drug-related offences, overcrowding 
prisons, and exposing imprisoned drug users to hardened criminals 
and further harms.2 Furthermore, the high prices of illicit drugs are 
Charles Parry is Director of the Alcohol & Drug Abuse Research 
Unit (ADARU) at the Medical Research Council (MRC) and 
an Extraordinary Professor in the Department of Psychiatry at 
Stellenbosch University. His interests include substance abuse 
epidemiology, alcohol and drug policy, and the effect of substance 
abuse on HIV and AIDS. Bronwyn Myers is a Specialist Scientist in 
the ADARU and an Honorary Associate Professor in the Department 
of Psychiatry & Mental Health at the University of Cape Town. Her 
interests include alcohol and drug intervention and services research 
and also drug policy. The authors indicate no conflicts of interest.
Corresponding author: C Parry (cparry@mrc.ac.za)
706
Forum
October 2011, Vol. 101, No. 10  SAMJ
often the direct consequence of the war that is waged against drug 
trafficking and often fuel drug selling and other drug-related crimes.7 
This law enforcement focus also has limited investment in and access 
to the broad range of evidence-based interventions for drug-related 
problems, apart from a few urban-based high-threshold treatment 
services required to contain the most problematic types of drug users.
What is required to make drug policy 
in South Africa more effective and 
humane?
To make progress in the drug policy arena, the South African 
government needs to reach consensus on several issues. The first 
is how it views different drugs of abuse. A study8 into the overall 
harms associated with 20 different substances (including alcohol 
and tobacco) across 16 different dimensions (including drug-related 
mortality, drug-related morbidity, dependence, environmental 
harms, and harms to families and communities) found that heroin, 
crack cocaine and methamphetamine held the most harms for 
people who use drugs, and alcohol, heroin and crack cocaine were 
the substances most harmful to others. Overall, alcohol was rated 
the most harmful substance, followed by heroin and crack cocaine. 
Tobacco was ranked the 6th most harmful substance, and cannabis 
was ranked 8th. However, in many countries, including South Africa, 
policy responses to drugs are not logical or based on evidence of the 
harmful nature of substances, as they criminalise the use of drugs 
such as cannabis that are less harmful than both tobacco and alcohol, 
which are legal substances. In line with Babor et al.,9 we contend 
that the risk of harm associated with drug use varies according to 
the nature of the substance being used and the pattern of use (i.e. 
frequency and quantity of use, and route of administration), and that 
drug policy should take such differences into account.
The second key issue is where South Africa’s drug policy should 
relate to international drug policy, and specifically where the country 
should orient itself in relation to law-enforcement and punitive drug 
policies versus public health-orientated policies (focused primarily on 
preventing and reducing the harms associated with drug use).2 Our 
position is that a rights-based, public health approach to drug policy 
that fosters the implementation of evidence-based interventions for 
drug prevention and treatment is the most effective and realistic 
approach to regulating drug use.3 This is in keeping with recent shifts 
in global thinking about drug policy, including within UN agencies 
that previously strongly supported law enforcement approaches. 
These policy shifts are based on evidence that the war on drugs has 
failed and has exposed people who use drugs to more health and 
social harms.2-3,10 Based on this global policy shift, we support calls 
for South African drug policy to move towards decriminalising drug 
use9 and adopting a rights-based, public health approach to drug 
policy focused on preventing and reducing the harms associated with 
drug use. It must be made clear that this is not the same as legalising 
the manufacture or growing of drugs or their distribution.  This 
approach also does not view drugs such as cannabis as harmless. 
Our view is that by decriminalising the personal use of drugs, funds 
spent on policing otherwise harmless people who use drugs could 
be redirected to preventing drug use as well as on public health 
interventions focused on problems such as driving while under the 
influence of drugs or aimed at users at high risk for harm or with 
patterns of use that are harmful.11
The third key issue relates to leadership, and specifically who 
should direct the development and implementation of policy in this 
area. A single agency should have overall authority to oversee the 
implementation of drug policy and must be fully accountable to the 
citizens of South Africa and report to Parliament on action taken and 
progress made. Our position is that this should be driven at a senior level 
of government through a body such as the IMC, but with input from 
technical experts within government and civil society and the support of 
a strengthened CDA. While it is important to consider local conditions 
when formulating and implementing a national drug strategy, much 
can be learned from international experience. For instance, Portugal has 
decriminalised possession of illicit drugs for a decade and a recent study 
found that Portugal has experienced reductions in problematic drug use, 
drug-related harms and criminal justice overcrowding.12
Finally, consensus must be reached on the short-, medium- and 
long-term priorities for policy. A good starting point is Babor et 
al.’s review of 43 commonly used drug policy interventions, of 
which 17 show evidence of effectiveness in at least one country.9 
Several comprise evidence-based interventions for people who use 
opiates, including opioid substitution treatment, heroin prescribing, 
and needle and syringe programmes for people who inject drugs. 
They also report benefits for psychosocial treatments and self-help 
organisations for people who use drugs. Some evidence was found 
for the effectiveness of regulatory interventions in the pharmaceutical 
area, including increasing the prices of certain medications, restricting 
certain over-the-counter (OTC) sales, requiring prescriptions (versus 
OTC availability), having prescription restrictions with registers, and 
monitoring of medicines with a high potential for harm.9
Regarding supply and control interventions, there is some evidence 
for the effectiveness of precursor chemical controls and interdiction, 
but that once drugs are made illegal there is a point beyond which 
increases in incarceration yield little added benefit.9 In fact, several 
studies show that shifting between conventional criminal penalties 
and some other form of penalty had modest or no effect on cannabis 
use, but reduced the adverse consequences for the person who 
used drugs. Interestingly, the review also listed several (commonly 
supported) drug polices for which there was no evidence of 
effectiveness, including use of mass media for prevention messaging, 
preventive interventions that merely involved giving information 
about the dangers of drugs, programmes where police give talks to 
children in classrooms, and drug testing in schools.9
In conclusion, we call for a move away from the political rhetoric of 
a ‘drug-free society’ and challenge government to start the real work 
of formulating and implementing an evidence-based drug policy. To 
achieve this, policymakers must engage with evidence about what 
works, and learn from the mistakes of other countries. This will 
require leadership and an investment in developing a workforce that 
can implement the policy. To ensure a return on this investment, 
policy evaluation processes should form an integral part of the new 
drug policy framework.
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